Status:

COMPLETED

Low Dose Chest Computed Tomography (CT) Screening

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

Princess Margaret Hospital, Canada

Conditions:

Hodgkin's Lymphoma

Eligibility:

All Genders

18+ years

Brief Summary

This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of year...

Eligibility Criteria

Inclusion

  • 5 years or longer from initial Hodgkin's disease diagnosis
  • Current age 18 or older
  • Received mediastinal irradiation and/or alkylating-agent based chemotherapy
  • Smoking history of 10-pack years or more, or current smoker

Exclusion

  • Patients with a history of lung cancer
  • Patients currently receiving treatment for another cancer diagnosis (patients with another cancer, but currently disease-free and not receiving treatment are eligible)
  • Patients with known diagnosis of any metastatic cancer
  • Pregnant women. Female patients must: be at least one year post-menopausal, have had a hysterectomy, or have a serum pregnancy test to confirm that they are not pregnant. These measures must be taken in order to avoid doing a CT scan of a pregnant woman.

Key Trial Info

Start Date :

August 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT01180010

Start Date

August 1 2010

End Date

September 1 2015

Last Update

December 29 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Health Network, Princess Margaret Hospital

Toronto, Ontario, Canada, M5G 2M9

Low Dose Chest Computed Tomography (CT) Screening | DecenTrialz